This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
antitrust regulators into pharmaceutical industry middlemen has been stymied because the companies have failed to provide many of the documents that, in some cases, were requested as far back as June 2022. A much-anticipated inquiry by U.S.
Irrespective of the approach, integration of CM in the pharma sector results in smaller factories, better process control, and environmental footprints, lower capital input, consistent product quality, modular manufacturing, and lower operating costs. million in 2022 and is predicted to reach USD 1,4290.95
Granules India Limited- Walk-In Drive for ITI, Diploma, B.Sc, B.Com Freshers On 14th Dec’ 2022. Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Passed out years: 2020/2021/ 2022. Date: 14th Dec’ 2022. Job Description. Location: Hyderabad.
Limited-Walk-In Drive for Production -Formulation (OSD) On 23rd Sept’ 2022. Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Date: 23rd Sept’ 2022. Kindly Carry the below Documents with you: . Granules India Pvt. Job Description.
I am pleased to announce our new 2022 Economic Report on U.S. Prescription Market (press release) We’re offering special discounted pricing if you order before March 28, 2022. The 2022 Economic Report on U.S. The chart below illustrates the depth and breadth of the 2022 edition. Click to Enlarge].
On 24th Sept’ 2022. SMS Pharmaceuticals Ltd is one of the leading pharmaceuticalmanufacturing companies in India with world -class facilities, with a wide range of process equipment fully compliant with the cGMP and WHO Standards. On 24th Sept’ 2022 @ SMS Pharmaceuticals Ltd, Unit-II, Bachupally, Hyderabad.
Limited-Walk-In Drive for Warehouse (OSD) On 16th Sept’ 2022. Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Walk-In Drive for Warehouse (OSD) On 16th Sept’ 2022 @ Granules India Limited (Gagillapur-Hyderabad). Date: 16th Sept’ 2022. Photograph.
Granules India Limited- Walk-In Drive for Granulation/ Compression/ Coating/ Capsule Filling/ QC/ Warehouse/ IPQA On 10th Dec’ 2022. Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Date: 10th Dec’ 2022. Kindly Carry the below Documents with you:
I am pleased to announce our new 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. The notable new material in this 2022-23 edition includes three new sections: Section 3.4.1. Section 6.1.6.
APL Health Care (Aurobindo )-Walk-In Interviews for Quality Assurance/ Quality Control On 2nd Dec’ 2022. APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Date : 2nd Dec’ 2022. Company Profile: Aurobindo Pharma Ltd’ (APL). Time: 09:00 AM to 02:00 PM.
Granules India Limited- Walk-In Interviews for Freshers & Experienced On 5th March 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Quality Control – 1 to 5 years experience BA/ B.Com/ B.Sc Freshers for Warehouse department. ITI/ Diploma/ B.Sc
The recent dip in transactional activity in 2022 and the increased borrowing costs through interest rate pressure have put deals under ever-increasing scrutiny. Due diligence teams will review your pharmaceutical quality system – to verify if it is operational and effective.
Granules India Limited- Walk-In Interviews for Freshers On 16th Feb’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian.
Granules India Limited- Walk-In Drive for Capsule Filling / Warehouse/ QC On 17th Feb’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Date: 17th Feb’ 2022 Time: 10:00 AM to 03:00 PM Venue: Granules India Limited, Sy.
Granules India Limited- Walk-In Interviews for Freshers in Warehouse/ Production On 17th Mar’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Passed out year: 2020 to 2022 Age: 18 -22 years Percentage: 60% & above in all Academics.
FDA Guidance on Testing High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol (Disclaimer: The article below includes a discussion of key points of the guidance document. It is not the guidance document, nor it is an alternative to the guidance document. The guidance document is available here: [link].)
The rationale for engaging with certain influencers and digital opinion leaders should be considered and documented. It is imperative to assess the risks of undue influence on HCPs, patients, and vulnerable groups, and of their use being perceived as improper promotion.
addresses the Inflation Reduction Act of 2022. we analyze the IRA’s likely consequences for wholesalers and the overall pharmaceutical business. There are 163 exhibits in this 2023-24 edition, compared with 150 in the 2022-23 edition. A new Section 6.3.2. In Subsection 6.5.1., In Subsection 6.5.2.,
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content